MO-0216 Hypofractionated IGRT for prostate cancer: first report on toxicity of a phase III randomized trial

E. Mazzeo, A. Bruni,C. Iotti, G. Frezza,B. Meduri, G. Guidi, F. Vigo, R. Vicini, M. Vernaleone, S. Ciabatti, E Cenacchi, A. Stefanelli, G. Miranda, S. Diquattro, A. Romeo,R. D'Amico, F. Bertoni,F. Lohr

Radiotherapy and Oncology（2023）

引用 0|浏览0